Related Experiment Video
Updated: Aug 8, 2026

10:47
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
Ion exchange tumor targeting: a new approach
A R Holmberg1, M Wilchek, M Márquez
1Karolinska Hospital, Cancer Center Karolinska, Stockholm, Sweden.
Summary
Bladder tumors show cation-exchange properties, selectively accumulating cationic dextran. This selective uptake in tumor tissue offers potential for targeted cancer therapies.
Area of Science:
- Biochemistry
- Oncology
- Biomaterials
Background:
- Extracellular matrix composition dictates tissue function.
- Charged groups in the extracellular matrix influence physiological processes.
- Ion exchange resin theory models charge-dependent transport.
Purpose of the Study:
- Investigate charge-dependent accumulation of dextran in tumor matrix.
- Determine if bladder tumor matrix exhibits ion exchange properties.
- Assess potential for selective cancer treatment via charge-modified dextran.
Main Methods:
- Ten patients with superficial urinary bladder carcinoma received intravesical instillations of technetium-99m-labeled charge-modified dextran derivatives.
- Radioactive uptake in normal and tumor tissues was measured post-resection.
- Uptake quotients (tumor:normal tissue) were calculated for cationic, anionic, and neutral dextran.
Main Results:
- Cationic dextran showed high uptake in tumor tissue (quotient up to 3000), with normal tissue having background activity.
- Anionic dextran resulted in low tumor uptake (quotient 1.8-2) and increased normal tissue uptake.
- Neutral dextran yielded a quotient up to 90, with no detectable radioactivity in blood.
Conclusions:
- Urinary bladder carcinomas exhibit cation-exchanging properties.
- Charge-modified dextran accumulation is dependent on matrix charge.
- This finding may lead to novel local treatment strategies for various cancers.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

